JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB51075

Anti-MT4-MMP antibody [EP1270Y]

5

(2 Reviews)

|

(18 Publications)

Rabbit Recombinant Monoclonal MT4-MMP antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 18 publications.

View Alternative Names

MT4MMP, MMP17, Matrix metalloproteinase-17, MMP-17, Membrane-type matrix metalloproteinase 4, Membrane-type-4 matrix metalloproteinase, MT-MMP 4, MTMMP4, MT4-MMP

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-MT4-MMP antibody [EP1270Y] (AB51075)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-MT4-MMP antibody [EP1270Y] (AB51075)

Immunofluorescent staining of HeLa cells using ab51075 (1 : 50).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MT4-MMP antibody [EP1270Y] (AB51075)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MT4-MMP antibody [EP1270Y] (AB51075)

ab51075 (1 : 50) staining human MT4-MMP in human lymphoma tissue by immunohistochemistry using paraffin embedded tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-MT4-MMP antibody [EP1270Y] (AB51075)
  • WB

Unknown

Western blot - Anti-MT4-MMP antibody [EP1270Y] (AB51075)

All lanes:

Western blot - Anti-MT4-MMP antibody [EP1270Y] (ab51075) at 1/1000 dilution

All lanes:

Mouse brain tissue lysate at 10 µg

Secondary

All lanes:

Goat anti-Rabbit HRP labeled at 1/2000 dilution

Predicted band size: 67 kDa

Observed band size: 58 kDa

false

Immunohistochemistry - Anti-MT4-MMP antibody [EP1270Y] (AB51075)
  • IHC

CiteAb

Immunohistochemistry - Anti-MT4-MMP antibody [EP1270Y] (AB51075)

Immunohistochemistry-immunofluorescence using Anti-MT4-MMP antibody [EP1270Y], ab51075. Publication image from Andrés, V. et al., 2018, Nat Commun, 29500407. Legend direct from paper.

EnhancedαM integrin-dependent crawling of MT4-MMP-null patrolling monocytes on CCL2-inflamed endothelium. a Representative intravital microscopy images of CD115+/Ly6C– patrolling monocytes (CD115 in red and Ly6C in green) crawling on the CCL2-inflamed endothelium in the cremaster muscle of wild-type (MT4+/+) and MT4-MMP-null (MT4–/–) mice; the recording was performed in the presence of anti-Itgam blocking antibody (M1/70) or IgG isotype control. Arrowheads, arrows, and dots respectively indicate individual patrolling monocytes, blood flow, and monocyte trajectory. Time of recording is indicated. b The graph shows the numbers of crawling patrolling monocytes recorded in a in every venule from five independent mice per genotype and condition in two independent experiments. c Quantification of CD115+Ly6G- rolling (left) and adherent (right) monocytes in the CCL2-inflamed endothelium in the cremaster muscle of wild-type (MT4+/+) and MT4-MMP-null (MT4–/–) mice. n = 8 mice per genotype in two independent experiments. Data were tested by one-way ANOVA followed by Bonferroni’s post test in b and by two-tailed Student’s t-test in c. Results are expressed as mean ± SEM.*p < 0.05, **p < 0.01, and ***p < 0.001

Immunohistochemistry - Anti-MT4-MMP antibody [EP1270Y] (AB51075)
  • IHC

CiteAb

Immunohistochemistry - Anti-MT4-MMP antibody [EP1270Y] (AB51075)

Immunohistochemistry-immunofluorescence using Anti-MT4-MMP antibody [EP1270Y], ab51075. Publication image from Andrés, V. et al., 2018, Nat Commun, 29500407. Legend direct from paper.

Lack of MT4-MMP in BM-derived cells results in increased macrophage burden in atherosclerotic plaques and accelerated AT. a Representative images of Mac3 immunostaining (red; nuclei in blue) in transverse sections of aortas from Ldlr–/– mice transplanted with MT4-MMP+/+ (MT4+/+) or MT4-MMP–/– (MT4–/–) BM cells and fed a HFD for 8 weeks; scale bar, 20 µm. The right panel shows Mac3-positive cells quantified by Image J. n = 6 mice per genotype in two independent experiments. b Representative images of en face Oil Red-stained aortas from BM-transplanted Ldlr–/– and fed a HFD for 8 or 12 weeks (left) and graph shows the area (%) of Oil Red-positive lesions in the aortic arch (right); n = 6 and n = 16 mice per genotype for 8 and 12 weeks in two and three independent experiments, respectively. c Representative images of transverse sections of aortic sinus stained with H&E of BM-transplanted Ldlr–/– mice; scale bar, 200 µm. d Stary scoring (I–VI) of aortic lesions of BM-transplanted Ldlr–/– mice, shown as a percentage of all mice for each condition after feeding a HFD for 8 or 12 weeks; n = 6 and n = 16 mice per genotype and time point in two and three independent experiments. e Bar graphs show the percentage of BM-transplanted Ldlr–/– mice for each range of % of necrotic area (left) and fibrotic cap thickness (right) after 12 weeks of HFD; n = 16 mice per genotype in three independent experiments. Data were tested by two-tailed Student’s t-test in a, by two-way ANOVA followed by Bonferroni’s post test in b, and by χ2-test for a trend in d, e. Results are expressed as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001

  • Carrier free

    Anti-MT4-MMP antibody [EP1270Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1270Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

ICC/IF, IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/100", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MT4-MMP also known as matrix metalloproteinase 17 is a membrane-type metalloprotease. This protein has an approximate mass of 62 kDa and is anchored to the cell membrane by a GPI-anchor. MT4-MMP is expressed mainly in the brain and reproductive tissues suggesting its specialized roles across different regions. This protease belongs to the MMP family which consists of enzymes that can degrade extracellular matrix components and shows unique substrate specificities compared to other MMPs.
Biological function summary

MT4-MMP functions in tissue remodeling and extracellular matrix degradation. It does not typically form a part of larger protein complexes but works independently or in association with other cell surface molecules. MT4-MMP breaks down specific substrates contributing to processes like development reproduction and repair mechanisms. Its activity regulates the availability of bioactive molecules and extracellular matrix components impacting cellular behavior and tissue structure.

Pathways

MT4-MMP is involved in pathways critical for cell migration and angiogenesis. It participates in the activation of growth factors and modulates signaling pathways such as those related to integrins and vascular endothelial growth factor (VEGF). MT4-MMP associates with proteins like TIMP-2 which modulates its activity providing a regulatory mechanism within these pathways. This balance between activation and inhibition affects physiological and pathological tissue remodeling.

MT4-MMP has been implicated in cancer progression and arthritis. Its overexpression or dysregulation can lead to increased degradation of the extracellular matrix facilitating tumor invasion and metastasis. In arthritis its role in degrading connective tissue components contributes to joint destruction. MT4-MMP interacts with other MMPs and inhibitors like TIMP-2 influencing disease outcomes. Understanding these interactions can help in designing therapeutic strategies targeting MT4-MMP in such diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Endopeptidase that degrades various components of the extracellular matrix, such as fibrin. May be involved in the activation of membrane-bound precursors of growth factors or inflammatory mediators, such as tumor necrosis factor-alpha. May also be involved in tumoral process. Cleaves pro-TNF at the '74-Ala-|-Gln-75' site. Not obvious if able to proteolytically activate progelatinase A. Does not hydrolyze collagen types I, II, III, IV and V, gelatin, fibronectin, laminin, decorin nor alpha1-antitrypsin.
See full target information MMP17

Publications (18)

Recent publications for all applications. Explore the full list and refine your search

Reports of biochemistry & molecular biology 13:329-340 PubMed40330566

2025

The Effect of Curcumin on the Activity of MMP-17 and MMP-24 in Hepatocytes of Mice Exposed to Thioacetamide.

Applications

Unspecified application

Species

Unspecified reactive species

Sahar Farzaneh,Masoud Salehipour,Farzaneh Tafvizi,Vahid Naseh

Current biology : CB 32:3460-3476.e6 PubMed35809567

2022

Src activation in lipid rafts confers epithelial cells with invasive potential to escape from apical extrusion during cell competition.

Applications

Unspecified application

Species

Unspecified reactive species

Kentaro Kajiwara,Ping-Kuan Chen,Yuichi Abe,Satoru Okuda,Shunsuke Kon,Jun Adachi,Takeshi Tomonaga,Yasuyuki Fujita,Masato Okada

Folia histochemica et cytobiologica 59:22-29 PubMed33560516

2021

miR-140-5p inhibits the proliferation, migration and invasion of vascular smooth muscle cells by suppressing the expression of NCKAP1.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Ma,Jiancheng Liu,Chunbo Li,Dong Wang

Biochemical and biophysical research communications 522:1009-1014 PubMed31813546

2019

MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuwen Yan,Nengqi Cao,Yeh Chen,Hsin-Yi Lan,Jong-Ho Cha,Wen-Hao Yang,Muh-Hwa Yang

Molecular medicine reports 21:508-516 PubMed31746394

2019

Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Hu,Xianzhe Dong,Tianyi Zhang,Hongming Ma,Wenshan Yang,Yichen Wang,Ping Liu,Yibang Chen

Molecular & cellular proteomics : MCP 17:1487-1501 PubMed29716987

2018

Click Chemistry-mediated Biotinylation Reveals a Function for the Protease BACE1 in Modulating the Neuronal Surface Glycoproteome.

Applications

Unspecified application

Species

Unspecified reactive species

Julia Herber,Jasenka Njavro,Regina Feederle,Ute Schepers,Ulrike C Müller,Stefan Bräse,Stephan A Müller,Stefan F Lichtenthaler

Nature communications 9:910 PubMed29500407

2018

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Cristina Clemente,Cristina Rius,Laura Alonso-Herranz,Mara Martín-Alonso,Ángela Pollán,Emilio Camafeita,Fernando Martínez,Rubén A Mota,Vanessa Núñez,Cristina Rodríguez,Motoharu Seiki,José Martínez-González,Vicente Andrés,Mercedes Ricote,Alicia G Arroyo

PloS one 12:e0184767 PubMed28926609

2017

Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo.

Applications

Unspecified application

Species

Unspecified reactive species

María José Blanco,Iván Rodríguez-Martín,Ana I R Learte,Cristina Clemente,María Gregoria Montalvo,Motoharu Seiki,Alicia G Arroyo,Cristina Sánchez-Camacho

Cellular physiology and biochemistry : internation 42:198-210 PubMed28531887

2017

Expression and Characterization of Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) and its Different Forms in Melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Bettina Hieronimus,Julian Pfohl,Christian Busch,Lutz Graeve

British journal of cancer 116:742-751 PubMed28196064

2017

MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.

Applications

Unspecified application

Species

Unspecified reactive species

Cassandre Yip,Pierre Foidart,Joan Somja,Alice Truong,Mehdi Lienard,Emilie Feyereisen,Hélène Schroeder,Stéphanie Gofflot,Anne-Françoise Donneau,Joëlle Collignon,Philippe Delvenne,Nor Eddine Sounni,Guy Jerusalem,Agnès Noël
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com